Anti-signal Recognition Particle Antibody-positive Necrotizing Myopathy with Secondary Cardiomyopathy: The First Myocardial Biopsy- and Multimodal Imaging-proven Case

Author:

Takeguchi-Kikuchi Shiori1,Hayasaka Taiki2,Katayama Takayuki1,Kano Kohei1,Takahashi Kae1,Saito Tsukasa1,Sawada Jun1,Minoshima Akiho2,Sakamoto Naka2,Akasaka Kazumi2,Miyokawa Naoyuki3,Nishino Ichizo4,Ishibashi-Ueda Hatsue5,Hasebe Naoyuki12

Affiliation:

1. Division of Neurology, First Department of Internal Medicine, Asahikawa Medical University, Japan

2. Division of Cardiology, First Department of Internal Medicine, Asahikawa Medical University, Japan

3. Department of Clinical Pathology, Asahikawa Medical University, Japan

4. Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan

5. Department of Pathology, National Cerebral and Cardiovascular Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Reference15 articles.

1. 1. Stenzel W, Goebel HH, Aronica E. Review: immune-mediated necrotizing myopathies - a heterogeneous group of diseases with specific myopathological features. Neuropathol Appl Neurobiol 38: 632-646, 2012.

2. 2. Kassardjian CD, Lennon VA, Alfugham NB, et al. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol 72: 996-1003, 2015.

3. 3. Miller T, Al-Lozi MT, Lopate G, et al. Myopathy with antibodyes to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73: 420-428, 2002.

4. 4. Valiyil R, Casciola-Rosen L, Hong G, et al. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodyes: A case series. Arthritis Care Res 62: 1328-1334, 2010.

5. 5. Suzuki S, Nishikawa A, Kuwana M, et al. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis 10: 61, 2015.

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3